2-oxospiro[indoline-3, 4 '-pyran] ketone compound as well as synthesis method and application of 2-oxo spiro [indoline-3, 4'-pyran] ketone compound
A technology of ketone compounds and indoline, applied in organic chemistry, drug combination, antineoplastic drugs, etc., can solve the problems of difficulty in obtaining novel and diverse structures, fewer types of synthesis methods, insufficient catalyst activity, etc., and achieve excellent cytotoxicity , Novel product structure, mild condition effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Example 1 Synthesis of 2-oxospiro[indoline-3,4'-pyrone] derivative 5
[0024] 1-phenyl-1,3-butanedione 2 or dibenzoylmethane 2' (0.42mmol), substituted isatins 3 (0.4mmol), malononitrile 4 (0.8mmol), Add base derivative 1 (0.08mmol) and 10mL acetonitrile into a 50mL round bottom flask, reflux at 80°C for 16h, after the reaction (TLC monitoring), wash with saturated NaHCO 3 (aqueous solution) to adjust pH = 7, the mixture was washed with CH 2 Cl 2 Extraction (50mL×3), combined organic layers, anhydrous Na 2 SO 4 Drying, removal of solvent under vacuum, purification of column chromatography to obtain product 5 (V 二氯甲烷 :V 甲醇 =80:1).
[0025] Concrete reaction route is as follows:
[0026]
[0027]
[0028] The synthetic process of each following compound is described in detail below:
[0029]
[0030] 1. Preparation of Compound 5a
[0031] The structural formula of compound 5a is: (R=-CH 3 R'=5-CH 3 )
[0032]
[0033] 1-phenyl-1,3-butanedione 2 (...
Embodiment 2
[0256] Embodiment 2 The antitumor activity of each product of the present invention
[0257] In this example, the anti-tumor activity of compound 5 on human liver cancer cells (HepG2), non-small cell lung cancer cells (247), human non-small cell lung cancer cells (A549) and human liver epithelial cells were tested by the MTT method. (THLE), human bronchial epithelioid cells (HBE) toxicity (with cisplatin (DPP) and doxorubicin (DOX) as positive controls), the test results are shown in Table 2.
[0258] Table 2 IC50 (μM) of compound 5 on three kinds of cell lines a
[0259]
[0260] a IC 50 Greater than or equal to 50μg / mL marked as "-"
[0261] The results in Table 2 show that: 8 compounds (5b, 5e, 5g, 5i, 5j, 5k, 5m, 5o) have good inhibitory effects on one or more of the above three cancer cell lines.
[0262] Compounds (5b, 5e, 5k, 5o) have good toxicity to human triple-positive breast cancer cells (MCF-7), and their IC 50 The values are all less than 100.00 μM. F...
Embodiment 3
[0265] The antibacterial activity of embodiment 3 each product of the present invention
[0266] Escherichia coli (18H5) carrying the NDM-1 gene recombinant plasmid and Staphylococcus aureus (18H8) carrying different drug-resistant genes isolated from the clinic, two drug-resistant bacteria and three common bacteria (Escherichia coli, gold Staphylococcus aureus (Staphylococcus aureus) and Klebsiella pneumoniae (Klebsiella pneumoniae), and Meropenem (Meropenem) was used as a positive control to test the antibacterial activity of the series of two types of 17 spirocyclic isatin compounds.
[0267] Use methanol to prepare the product to 10 μM, suck 6 μL into a new centrifuge tube, wait for the methanol to evaporate to leave a quantitative solid product, add 6 μL DMSO and 294 μL Luria-Bertani (LB) solution (to ensure that the DMSO solution in the final 96-well plate is less than 2%), thus the product is made into a 200 μM sample and then diluted to 20 μM and 2 μM with LB solution ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| melting point | aaaaa | aaaaa |
| melting point | aaaaa | aaaaa |
| melting point | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 
![2-oxospiro[indoline-3, 4 '-pyran] ketone compound as well as synthesis method and application of 2-oxo spiro [indoline-3, 4'-pyran] ketone compound](https://images-eureka.patsnap.com/patent_img/8854ab81-3f15-44cc-af26-80e914886df4/FDA0002633653040000012.png)
![2-oxospiro[indoline-3, 4 '-pyran] ketone compound as well as synthesis method and application of 2-oxo spiro [indoline-3, 4'-pyran] ketone compound](https://images-eureka.patsnap.com/patent_img/8854ab81-3f15-44cc-af26-80e914886df4/BDA0002633653050000011.png)
![2-oxospiro[indoline-3, 4 '-pyran] ketone compound as well as synthesis method and application of 2-oxo spiro [indoline-3, 4'-pyran] ketone compound](https://images-eureka.patsnap.com/patent_img/8854ab81-3f15-44cc-af26-80e914886df4/BDA0002633653050000021.png)